NLRP3 and type 2 diabetes mellitus: There is also evidence in a rat model of type 2 diabetes that Nlrp3 gene silencing ameliorates cardiac inflammation, fibrosis, and function and that NLRP3 inflammasome activation is mediated by increased oxidative stress-induced NF-kB activation [37].